Sofosbuvir Withdrawn Phase 4 Trials for Hematopoietic Stem Cell Transplantation (HSCT) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03279133Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.